Itron (NASDAQ:ITRI) SVP Christopher Ware Sells 4,486 Shares

Itron, Inc. (NASDAQ:ITRIGet Free Report) SVP Christopher Ware sold 4,486 shares of the business’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total value of $446,536.44. Following the completion of the transaction, the senior vice president directly owned 31,806 shares in the company, valued at approximately $3,165,969.24. This represents a 12.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Itron Stock Performance

Shares of NASDAQ:ITRI opened at $95.21 on Tuesday. The business has a 50-day moving average price of $97.72 and a two-hundred day moving average price of $109.72. The stock has a market capitalization of $4.28 billion, a P/E ratio of 14.63, a P/E/G ratio of 0.86 and a beta of 1.48. Itron, Inc. has a 1-year low of $88.57 and a 1-year high of $142.00. The company has a current ratio of 1.80, a quick ratio of 1.56 and a debt-to-equity ratio of 0.45.

Itron (NASDAQ:ITRIGet Free Report) last released its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.19 by $0.27. Itron had a net margin of 12.72% and a return on equity of 20.04%. The business had revenue of $571.66 million for the quarter, compared to analyst estimates of $561.31 million. During the same quarter last year, the firm earned $1.35 EPS. Itron’s quarterly revenue was down 6.7% compared to the same quarter last year. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Equities analysts predict that Itron, Inc. will post 5.33 earnings per share for the current year.

Institutional Investors Weigh In On Itron

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in Itron by 2.3% during the third quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company’s stock valued at $731,809,000 after buying an additional 132,329 shares during the period. Impax Asset Management Group plc boosted its stake in Itron by 127.3% during the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after buying an additional 890,040 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Itron by 18.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company’s stock worth $118,034,000 after acquiring an additional 194,768 shares during the last quarter. Geode Capital Management LLC boosted its stake in Itron by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock worth $106,340,000 after buying an additional 6,598 shares in the last quarter. Finally, Handelsbanken Fonder AB increased its holdings in shares of Itron by 6.0% in the third quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company’s stock worth $124,545,000 after buying an additional 56,318 shares during the period. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Itron News Summary

Here are the key news stories impacting Itron this week:

  • Positive Sentiment: Recent quarterly results and forward guidance beat expectations — Itron reported a meaningful EPS beat and set Q1 and FY2026 EPS guidance that suggests continued profitability, which supports valuation metrics and earnings expectations for the year.
  • Neutral Sentiment: Heavy trading activity — intraday volume is well above the stock’s average, indicating that today’s moves are driven by newsflow (insider transactions and debt issuance) rather than thin trading.
  • Negative Sentiment: Large, clustered insider selling by multiple senior executives — over Feb. 19–20 several SVPs, the CFO and the CAO sold shares (sales concentrated around ~$99.50–$100.17), totaling roughly 46–48k shares across the filings. Executives who trimmed positions include the CFO Joan Hooper, John Marcolini, Donald Reeves III, Justin K. Patrick, Laurie Ann Pulatie‑Hahn and others. Large insider sales can be read negatively by the market (potential signaling or increased supply).
  • Negative Sentiment: Itron announced $600 million of convertible senior notes — while this raises capital and may be used for corporate purposes, convertible debt introduces potential future dilution and can be viewed as a negative near-term catalyst until use of proceeds and conversion terms are clearer. Itron Announces $600.0 Million Convertible Senior Notes

Analysts Set New Price Targets

Several research analysts have recently commented on ITRI shares. Stephens upgraded Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 target price for the company in a research note on Monday, November 3rd. Wall Street Zen downgraded Itron from a “buy” rating to a “hold” rating in a research report on Wednesday, January 14th. Weiss Ratings cut shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Johnson Rice upgraded Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective for the company in a research report on Monday, January 5th. Finally, Robert W. Baird set a $128.00 price target on shares of Itron and gave the stock an “outperform” rating in a report on Wednesday, February 18th. Eight analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $137.90.

Read Our Latest Stock Report on ITRI

Itron Company Profile

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Read More

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.